isoxazoles has been researched along with Heart Defects, Congenital in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, J; Hama, K; Inoue, A; Kano, K; Kawahara, A; Nakanaga, K; Nishina, H; Saigusa, D; Sato, T; Tokuyama, H; Tomioka, Y; Yukiura, H | 1 |
| Book, WM; Lee, EK; Lyle, TA; McConnell, ME; Mehta, PK; Simpson, L | 1 |
2 other study(ies) available for isoxazoles and Heart Defects, Congenital
| Article | Year |
|---|---|
Overexpression of autotaxin, a lysophosphatidic acid-producing enzyme, enhances cardia bifida induced by hypo-sphingosine-1-phosphate signaling in zebrafish embryo.
Topics: Animals; Down-Regulation; Embryo, Nonmammalian; Heart Defects, Congenital; HEK293 Cells; Humans; Isoxazoles; Lysophospholipids; Phenotype; Phosphoric Diester Hydrolases; Propionates; Receptors, Lysophosphatidic Acid; RNA, Messenger; Signal Transduction; Sphingosine; Zebrafish | 2014 |
Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Bosentan; Dose-Response Relationship, Drug; Drug Administration Schedule; Eisenmenger Complex; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Exercise Test; Female; Heart Defects, Congenital; Humans; Isoxazoles; Male; Middle Aged; Oxygen; Retrospective Studies; Sulfonamides; Thiophenes | 2008 |